Are Multivitamins Worth Taking? The Evidence Review

The multivitamin is the world's most popular supplement, taken daily by roughly one-third of American adults. It is also one of the most argued-about in clinical nutrition circles. The debate has become more nuanced in recent years as large, well-designed randomized controlled trials have reported modest — but real — benefits that simple "eat your vegetables" messaging did not predict.

The Large Trial Evidence

For decades, observational studies suggested multivitamin users had better health outcomes. Critics correctly noted that multivitamin users tend to be wealthier, more health-conscious, and have better diets — confounding that makes observational data nearly worthless for this question.

The Physicians Health Study II (PHSII, n=14,641 male physicians, 11.2 years) was the first large RCT to test multivitamins against placebo rigorously. Results: a modest but statistically significant 8% reduction in total cancer incidence. No significant effect on cardiovascular events. No effect on mortality.

The COSMOS trial (COcoa Supplement and Multivitamin Outcomes Study, n=21,442, approximately 5 years) tested a multivitamin-mineral supplement against placebo. Cancer results: statistically significant 13% reduction in total cancer incidence, with a stronger effect (22% reduction) when the first two years were excluded (accounting for pre-existing undiagnosed cancers). Cardiovascular disease: no significant reduction in primary outcomes. Mortality: no significant reduction.

The COSMOS-Mind substudy examined cognitive outcomes in 2,262 participants for 3 years and found a statistically significant improvement in global cognition and memory, equivalent to approximately 1.8 years of age-related cognitive protection. This finding has been replicated in a subsequent independent trial.

These are not dramatic results. They are also not nothing — particularly the cognitive data, which showed up in two independent well-powered trials.

The Bioavailability Problem

Not all multivitamins are equal, and the cheapest options often use forms with poor bioavailability that limit their effectiveness.

Magnesium oxide: roughly 4% absorption. Magnesium glycinate or malate: 40-50% absorption. Many budget multivitamins use oxide to hit label claims cheaply.

Folate as folic acid versus methylfolate: approximately 10-15% of people carry MTHFR gene variants that impair folic acid conversion to the active form (5-methyltetrahydrofolate). Multivitamins using methylfolate bypass this limitation entirely.

Vitamin B12 as cyanocobalamin versus methylcobalamin: absorption differences are modest for most people, but methylcobalamin may be preferable for individuals with impaired methylation.

Vitamin K1 versus K2: most multivitamins use K1 (phylloquinone), which supports coagulation. K2 (menaquinone, particularly MK-7) has better evidence for bone and cardiovascular tissue-level benefits due to superior distribution to these tissues.

Iron inclusion: multivitamins with iron can interfere with absorption of other minerals (zinc, calcium, magnesium) if taken simultaneously. Post-menopausal women and men rarely need supplemental iron, and routine iron in multivitamins can cause GI discomfort unnecessarily.

Who Actually Benefits

The evidence suggests multivitamins offer the most value for people with dietary gaps, which is more common than typically acknowledged. NHANES data consistently shows large portions of Americans fall below estimated average requirements for vitamin D, magnesium, calcium, and potassium. Micronutrient inadequacies are common even in people who believe they eat well.

Populations with clearest potential benefit: older adults (reduced absorption of B12, D, calcium with aging), vegans and vegetarians (B12, D, zinc, omega-3 gaps), people with restricted calorie intake, individuals with malabsorption conditions, and people eating highly processed diets.

Populations with the least benefit: young adults eating varied whole-food diets with adequate sun exposure. For these individuals, a multivitamin largely results in expensive urine.

FAQ

Q: Should I take a multivitamin if I eat a good diet?

"Good diet" is self-reported and unreliable. If you track your micronutrient intake for a week using a food logging app and find consistent adequacy across vitamin D, magnesium, zinc, B12, folate, and iron (or ferritin via blood test), your diet may genuinely be adequate. Most people who think they eat well have gaps in 2-4 of these. A multivitamin as insurance is low-risk and modestly evidence-supported.

Q: What should I look for in a quality multivitamin?

Methylated B vitamins (methylfolate, methylcobalamin), magnesium glycinate or malate rather than oxide, no iron unless you have documented deficiency or are menstruating, and third-party testing certification (USP, NSF, Informed Sport). The price difference between cheap and quality formulations is often $10-20 per month — worth it for better bioavailability.

Q: Can multivitamins cause harm?

Rarely, in specific circumstances. High-dose vitamin A (common in some multivitamins at 5000+ IU as retinol) can cause toxicity with long-term excess and is teratogenic in pregnancy. Too much vitamin E (above 400 IU synthetic dl-alpha tocopherol) has been associated with slightly increased all-cause mortality in meta-analyses. These concerns argue for moderation in dosing — not for avoiding multivitamins entirely.

Related Articles

• Do Multivitamins Actually Work? What the Science Says
• How Long Does Bacopa Take to Work? Timeline of Effects and Benefits
• BCAA Supplements: Leucine, Isoleucine, and Valine Science
• Collagen Supplements: The Skin and Joint Claims vs. the Evidence
• Creatine Myths Debunked: The Most Studied Supplement Explained

Track your supplements in Optimize.